Cipherome Patents – Insights & Stats (Updated 2023)

Cipherome has a total of 44 patents globally, out of which 23 have been granted. Of these 44 patents, more than 65% patents are active. The USA is where Cipherome has filed the maximum number of patents, followed by South Korea. Parallelly, South Korea seems to be the main focused R&D center of Cipherome and the United States is the origin country of the firm.

Cipherome was founded in the year 2016 by Ju Han Kim. The company provides artificial intelligence and machine learning solutions for drug related treatment.

Do read about some of the most popular patents of Cipherome which have been covered by us in this article and also you can find Cipherome patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Cipherome patent portfolio.

How many patents does Cipherome have?

Cipherome has a total of 44 patents globally. These patents belong to 10 unique patent families. Out of 44 patents, 29 patents are active.

How Many Patents did Cipherome File Every Year?

Cipherome Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCipherome Applications FiledCipherome Patents Granted
20223
202157
202014
201914
20181
201722
2016171
201521
201416

How many Cipherome patents are Alive/Dead?

Worldwide Patents

Cipherome Patent Portfolio

How Many Patents did Cipherome File in Different Countries?

Cipherome Worldwide Patent Filing

Countries in which Cipherome Filed Patents

CountryPatents
United States Of America9
Korea (South)6
Europe5
Norway3
China3
Spain3
Germany3
Austria3
Japan2
Hong Kong (S.A.R.)1
Italy1

Where are Research Centres of Cipherome Patents Located?

R&D Centres of Cipherome

Most Cited Cipherome Patent

CN109074428A is the most popular patent in the Cipherome portfolio. It has received 3 citations so far.

List of Cipherome Patents

Cipherome PatentsTitle
US11195594B2Method For Selecting Anticancer Agent Based On Protein Damage Information Of Individual To Prevent Anticancer Agent Side Effects
US10950326B2Method For Personalized Selection Of A Drug For A Subject
US10896743B2Secure Communication Of Nucleic Acid Sequence Information Through A Network
US20220044829A1Interactive User Interface For Providing Treatment Information
US20210327553A1Prediction Of Adverse Drug Reaction Based On Machine-Learned Models Using Protein Function Scores And Clinical Factors
US20210241849A1Method For Personalized Selection Of A Drug For A Subject
US20210104298A1Secure Communication Of Nucleic Acid Sequence Information Through A Network
EP3261008B1Method For Selecting Anticancer Agent Based On Protein Damage Information Of Individual To Prevent Anticancer Agent Side Effects
EP3495504B1Method And System For Selecting Drug On Basis Of Individual Protein Damage Information For Preventing Side Effects Of Drug
EP3037548B1Method And System For Selecting Drug On Basis Of Individual Protein Damage Information For Preventing Side Effects Of Drug
EP4136641A1Prediction Of Adverse Drug Reaction Based On Machine-Learned Models Using Protein Function Scores And Clinical Factors
CN111710434BMethods And Systems For Determining Effects On The Function Of Proteins
CN105940114BComputer Readable Medium And System For Drug Selection
ES2891903T3Method For Selecting Antineoplastic Agent Based On Protein Damage Information Of Individuals To Avoid Antineoplastic Agent Side Effects
DE602016063446T2Procedure For Selecting An Anti-Cancer Drug Based On The Individual’S Protein Damage Information To Prevent Side Effects Of The Anti-Cancer Drug
ES2832886T3Method And System For Selecting A Drug Based On Individual Protein Damage Information To Prevent Side Effects Of A Drug
DE602014071149T2Method And System For Selecting A Drug Based On Individual Protein Damage Information To Avoid The Adverse Effects Of Drug
ES2720999T3Method And System For Selecting A Drug Based On Individual Protein Damage Information To Prevent Side Effects Of A Drug
DE602014042981T2Method And System For Selecting A Drug Based On Individual Protein Damage Information To Avoid The Adverse Effects Of Drug
IT202000117752T2Method And System For Selecting A Drug On The Basis Of Individual Information Of Protein Damage For The Prevention Of Side Effects Of The Drug.
NO3495504B1Method And System For Selecting Drug On Basis Of Individual Protein Damage Information For Preventing Side Effects Of Drug
NO3261008B1Method For Selecting Anticancer Agent Based On Protein Damage Information Of Individual To Prevent Anticancer Agent Side Effects
NO3037548B1Method And System For Selecting Drug On Basis Of Individual Protein Damage Information For Preventing Side Effects Of Drug
KR102482818B1Method For Personalized Prevention Of Adverse Drug Reaction Of Osteoporosis Medication Based On Information Of Individual Deleterious Protein Sequence Variation
KR102482819B1Method For Personalized Prevention Of Adverse Drug Reaction Of Anticancer Drug Based On Information Of Individual Deleterious Protein Sequence Variation
JP6266110B2Drug Selection Method And System Based On Individual Protein Damage Information For Drug Side Effect Prevention
KR101788673B1Method For Protecting Nucleic Acid Sequence Data Security And Computer Readable Storage Medium Storing The Method
KR101524562B1Method And System For Personalized Prevention Of Adverse Drug Reaction Based On Information Of Individual Deleterious Protein Sequence Variation
HK40010016A1Method And System For Selecting Drug On Basis Of Individual Protein Damage Information For Preventing Side Effects Of Drug
US20180068056A1Method And System For Selecting Drug On Basis Of Individual Protein Damage Information For Preventing Side Effects Of Drug
US20170357751A1Computer-Implemented Evaluaton Of Drug Safety For A Population
EP3387570A1Computer-Implemented Evaluaton Of Drug Safety For A Population
CN109074428AComputer-Implemented Evaluaton Of Drug Safety For A Population
WO2021211881A1Prediction Of Adverse Drug Reaction Based On Machine-Learned Models Using Protein Function Scores And Clinical Factors
WO2017100794A1Computer-Implemented Evaluaton Of Drug Safety For A Population
WO2016133375A1Method For Selecting Osteoporosis Therapeutic Agent Based On Protein Damage Information Of Individual To Prevent Osteoporosis Therapeutic Agent Side Effects
WO2016133374A1Method Of Selecting Uterine Contraction Inhibiting Agent Based On Protein Damage Information On Each Individual To Prevent Side Effects Of Uterine Contraction Inhibiting Agent
WO2016133373A1Method For Selecting Anticancer Agent Based On Protein Damage Information Of Individual To Prevent Anticancer Agent Side Effects
AT1428651TMethod of Selecting an Anticancer Drug Based on the Individual’s Protein Damage Information to Prevent Side Effects of the Anticancer Drug
AT1321212TMethod and system for selecting a drug based on individual protein damage information to avoid the side effects of drugs
AT1107722TMethod and system for selecting a drug based on individual protein damage information to avoid the side effects of drugs
JP2019505934AComputer-Implemented Population Drug Safety Assessments
KR1020180124840AComputer-Implemented Evaluaton Of Drug Safety For A Population
KR1020160101706AMethod For Personalized Prevention Of Adverse Drug Reaction Of Tocolytics Based On Information Of Individual Deleterious Protein Sequence Variation

What are Cipherome’s key innovation segments?

What Technologies are Covered by Cipherome?

The chart below distributes patents filed by Cipherome in different countries on the basis of the technology protected in patents. It also represents the markets where Cipherome thinks it’s important to protect particular technology inventions.

R&D Focus: How has Cipherome’s search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Cipherome?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.